Related Experiment Video

Updated: Jul 6, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients

Margaret L Stuber1, Eyal Shemesh, Debra Seacord

  • 1Mattel Children's Hospital, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. mstuber@mednet.ulca.edu

Pediatric Transplantation
|March 12, 2008
PubMed

Insights

Non-adherence to immunosuppressants after pediatric liver transplant is common. Monitoring tacrolimus blood level variability (s.d.) may predict organ rejection, enabling earlier interventions.

Area of Science:

  • Pediatric Transplant Medicine
  • Pharmacokinetics
  • Immunosuppression Management

Background:

  • Non-adherence to immunosuppressants is a primary cause of graft loss in pediatric liver transplant recipients.
  • Current methods for measuring medication adherence lack validation and defined thresholds, hindering intervention effectiveness.
  • Tacrolimus blood level variability has been proposed as an indicator of medication adherence.

Purpose of the Study:

  • To identify a specific threshold for the standard deviation (s.d.) of tacrolimus blood levels associated with rejection episodes in pediatric liver transplant patients.
  • To evaluate the utility of monitoring tacrolimus blood level fluctuations for detecting non-adherence prior to clinical rejection.

Main Methods:

  • Retrospective analysis of tacrolimus blood levels from 96 pediatric liver transplant recipients at UCLA Medical Center.
  • Statistical analysis to determine the optimal threshold value of the standard deviation of individual tacrolimus blood levels.
  • Comparison of identified thresholds with previously suggested values (e.g., s.d. of 3.0).

Main Results:

  • Analysis of retrospective data supported a previously suggested threshold of 3.0 for tacrolimus blood level s.d.
  • Further analysis indicated that a standard deviation threshold of 2.5 provided a better fit for the study data.
  • These findings highlight the potential of s.d. monitoring for adherence assessment.

Conclusions:

  • Monitoring the standard deviation of routine tacrolimus blood levels can serve as a valuable tool in pediatric liver transplant recipients.
  • This method may allow for the early detection of non-adherence to immunosuppressants before clinical signs of organ rejection appear.
  • Implementing s.d. monitoring can facilitate timely interventions to improve long-term graft survival.

More Related Videos

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...